APOE and hyperlipidemia: Since 1998, when the ApoE KO mouse model was employed for studies of atherosclerosis and hyperlipidemia (Hofker et al., 1998), it has not been shown how LDLs contribute to specific effects on AdvSCA-1+ cells.